Behandler Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 1 Year 7 Months
About Behandler Pharmaceuticals
Behandler Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2023 (One year and seven months 15 days old ). Its registered office is in Theni, Tamil Nadu, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Senthilkumar Murugesan, Anandkumar, Chellaperumal Devi, and Two other members serve as directors at the Company.
Company Details
-
Location
Theni, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721TN2023PTC161461
-
Company No.
161461
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Who are the key members and board of directors at Behandler Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilkumar Murugesan
|
Director | 28-Jun-2023 | Current |
| Anandkumar | Director | 07-Jun-2024 | Current |
|
Chellaperumal Devi
|
Director | 09-Jan-2024 | Current |
|
Rathakrishnan Sriranjani
|
Director | 27-Jun-2023 | Current |
|
Alagarsamy Saathveega
|
Director | 27-Jun-2023 | Current |
Financial Performance of Behandler Pharmaceuticals.
Enhance accessibility to Behandler Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Behandler Pharmaceuticals?
Unlock access to Behandler Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Confervo Formulations Private LimitedSenthilkumar Murugesan is a mutual person
-
Pharmacien Life Sciences Private Limited
Senthilkumar Murugesan is a mutual person
-
Victomed Pharmaceuticals Private Limited
Senthilkumar Murugesan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Behandler Pharmaceuticals?
Unlock and access historical data on people associated with Behandler Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Behandler Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Behandler Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.